Minerva Neurosciences Files 8-K on Shareholder Votes
Ticker: NERV · Form: 8-K · Filed: Dec 5, 2024 · CIK: 1598646
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: MINV
TL;DR
MINV filed an 8-K for a shareholder vote. Standard governance stuff.
AI Summary
Minerva Neurosciences, Inc. filed an 8-K on December 5, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31).
Why It Matters
This filing indicates that Minerva Neurosciences held a shareholder vote, which is a routine but important corporate governance event that can impact company direction.
Risk Assessment
Risk Level: low — This is a routine 8-K filing regarding a shareholder vote, which typically does not involve significant new financial or operational information.
Key Numbers
- 001-36517 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-0784194 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- December 5, 2024 (date) — Date of report
FAQ
What specific matters were submitted to a vote of security holders?
The filing states it is for 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals in the provided text.
When was the earliest event reported in this 8-K?
The earliest event reported was on December 5, 2024.
What is Minerva Neurosciences, Inc.'s principal executive office address?
The address is 1500 District Avenue, Burlington, MA 01803.
What is the company's telephone number?
The company's telephone number is (617) 600-7373.
What is the SIC code for Minerva Neurosciences, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 553 words · 2 min read · ~2 pages · Grade level 13.7 · Accepted 2024-12-05 17:21:01
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NERV The Nasdaq
Filing Documents
- d870520d8k.htm (8-K) — 30KB
- 0001193125-24-271652.txt ( ) — 145KB
- nerv-20241205.xsd (EX-101.SCH) — 3KB
- nerv-20241205_lab.xml (EX-101.LAB) — 17KB
- nerv-20241205_pre.xml (EX-101.PRE) — 11KB
- d870520d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MINERVA NEUROSCIENCES, INC. Date: December 5, 2024 By: /s/ Frederick Ahlholm Frederick Ahlholm Chief Financial Officer